During the past decade, Covance Clinical Research Unit Inc. conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 10 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 7 clinical trials were completed. i.e. 46.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covance Clinical Research Unit Inc." #1 sponsor was "Bristol-Myers Squibb" with 5 trials, followed by "Genentech, Inc." with 4 trials sponsored, "Kubota Vision Inc." with 3 trials sponsored, "Aegerion Pharmaceuticals, Inc." with 2 trials sponsored and "Agios Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covance Clinical Research Unit Inc." #1 collaborator was "Covance" with 2 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 2 trials as a collaborator, "Analytisch-biologisches Forschungslabor GmbH" with 1 trials as a collaborator, "Arista Laboratories" with 1 trials as a collaborator and "Covance IVRS" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Covance Clinical Research Unit Inc." are "Healthy" (12 trials), "Healthy Volunteers" (9 trials), "Healthy Participants" (3 trials), "Healthy Volunteer" (3 trials) and "Drug-drug Interaction" (2 trials). Many other conditions were trialed in "Covance Clinical Research Unit Inc." in a lesser frequency.

Most popular intervention types in "Covance Clinical Research Unit Inc." are "Drug" (45 trials), "Other" (5 trials), "Biological" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Itraconazole" (5 trials), "ACU-4429" (3 trials), "Midazolam" (3 trials) and "lomitapide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Covance Clinical Research Unit Inc." are 46 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Covance Clinical Research Unit Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Covance Clinical Research Unit Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Covance Clinical Research Unit Inc., 44 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Covance Clinical Research Unit Inc. has several departments that took part in Clinical trials: "Covance Research Unit - Daytona" - 6 trials